1/66
Looks like no tags are added yet.
____ acts on contractility
inotropes
rate of heart contraction (HR)
chronotrophy
conduction velocity of of electrical signals in the heart
dromotrophy
how quickly heart relaxes and recover during diastole
lusitropy
Cardiac output (CO)=
cardiac rate x stroke volume
how much blood is coming back to heart (fluid volume aka the amount of blood returning via venous return) and is heavily influenced by renal excretion and diuretics
preload
what happens in vessels → TPR (total peripheral resistance) is determined by vascular tone
more vasoconstriction = 👆 TPR = more hard for heart to pump blood out
afterload
Pathway of NE to increase heart contractility via cAMP:
NE binds to B1 adrenergic receptors (Gs-coupled)
activation of Gs protein stimulates adenylate cyclase
adenylate cyclase convert ATP to cAMP → raises intracellular cAMP levels
high cAMP levels activates Protein Kinase A → allows extracellular calcium to enter cardiomyocytes AND phosphorylates calcium in sarcoplasmic reticulum (this triggers release of steroid calcium from SR into cytoplasm)
influx and release of calcium causes calcium to bind to troponin C → shifts tropomyosin out of the way, allowing actin and myosin to bind
formation of actin-myosin crossbridges drives the sliding of muscle filaments, resulting in strong force of contraction (positive inotrophy)
PDE3: enzyme found in caardiomyocytes that is responsible for the breakdown of cAMP
inhibition of PDE3 leads to ______
increase cAMP which increase force of contraction
____ inotropes will INCREASE myocardial contractility
positive
MOA of inotropic agents
Key mechanisms include:
↑ intracellular calcium availability in cardiac myocytes.
↑ sympathetic nervous system stimulation.
Modulating cyclic AMP pathways.
Impact on cardiac output and workload: improved stroke volume but ↑ myocardial oxygen consumption.
this means ____
this is a problem in pt with CAD
list the catecholamine drugs
dobutamine, dopamine, epinephrine, norepinephrine, isoproterenol
MOA of catecholamines
B-1 receptor agonists
what is the effect of catecholamines
Increased cAMP
list the PDE3i
milrinone
PDE3i are also known as
inodilators
MOA of PDE3i
prevents cAMP breakdown
effects of PDEi
increase cAMP levels independent of B-1 receptor activation, leading to increased myocardial contractility and vasodilation.
PDE3i is used for
decompensated heart failure
dobutamine is a catecholamine, its MOA is
selective B1 agonist
dobutamine is used for
cardiogenic shock and HF with decreased output
dopamine is dose dependent
low= dopaminergic receptors
medium= B1
high= A1
epinephrine MOA
combined beta and alpha agonist
epinephrine effects
increase cardiac output and BP
isoproterenol MOA
nonselective B1/B2 agonist
isoproterenol effects
increases heart rate and decreases SVR
list the cardiac glycosides
digoxin
digoxin MOA
inhibits Na+/K+ ATPase
digoxin effects
increasing intracellular calcium
list which categories are cAMP dependent
catecholamines and PDE3i
list cAMP dependent drugs
digoxin
CI for dobutamine
tachyarrhymias, ischemic hypotension, effects are blunted on B-blockers, tolerance by 72 hours
dopamine effects
DA= renal vasodilation, B1= ino/chronotropy, A1= vasoconstriction
dopamine ADR
arrhythmias, extravasation
epinephrine use
refractoru shock, cardiac arrest, anaphylaxis
CI for epinephrine
increase lactate, increased glucose, arrhythmias
use of isoproterenol:
bradyarrhythmias, torsades bridging
isoproterenol CI
hypotension, tachycardias, ischemias
norephinephrine MOA
stimulates A1 > B1
NE effects
increased SVR and BP
NE use
vasopressor in septic and cardiogenic shock
NE ADRs
reflex bradycardias, extravasation
milirinone MOA
PDE3i
milrinone effects
increase cAMP in myocardium and vessels leading to positive inotropy, lusitropy and vasodilation.
renal fact about milrinone
decrease dose in renal impairment
milrinone use
right ventricular failure and pulmonary HTN
milrinone ADR
hypotension due to vasodilation, arrhythmias, thrombocytopenias
digoxin effects
mild inotrophy and vagal AV nodal slowing
digoxin MOA with antiport
digoxin binds to Na+/K+ pump in same place where K+ binds → inhibits
_____ is an antiport that uses high Na+ concentration created by the Na+/K+ pump to pump out calcium
therefore, decreased Na+ concentration makes this exchanger less effective = Ca2+ is stuck in cell → leads to more contractions
Na+/Ca2+
digoxin elimination
renal
digitoxin metabolism
hepatic (Liver)
digoxin electrolytes interactions:
with HYPERkalemia
decrease digoxin binding to Na+/K+ pump, reducing effectiveness
digoxin electrolytes interactions:
with HYPOkalemia
increase digoxin binding to Na+/K+ pump, increasing toxicity
digoxin electrolytes interactions:
HYPERcalcemia
arrhythmias and increased toxicity
digoxin electrolytes interactions:
HYPOmagenesia
arrhythmias and increased toxicity
digoxin ADRs
visual halos/yellow green vision, bradyarrhythmias (most dangerous is 2° AV block)
digoxin antidote
digibind
digibind elimination
renal
digibind ADR
hypersensitivity
digibind CI
sheep sensitivity, papin, papaya extract
digoxin is pumped out by ____
pgp
digoxin DDIs:
these drugs blocks pgp, INCREASING digoxin levels
amiodarone, dronedarone, verapamil, quinidine, azole antifungals and macrolides (erythromycin, fluconazole, spironolactone)
which digoxin DDI is potassium sparing, this increases K+ levels and makes it harder for digoxin to bind = decreased effiacy
spironolactone
which digoxin DDI causes decrease in potassium, increasing digoxin toxicity due to less compition at Na/K pump
loop and thiazide diuretics
which digoxin DDI adds to digoxin’s vagal slowing of SA and AV nodal conduction, leading to the additive effect of severe bradycardia and complete AV block
b-blockers and nonDHP CCBs
which digoxin DDI binds to digoxin and prevents absorption, leading to loss of therapeutic effects
cholestyramine, antacids, kaolin
which digoxin DDI induces pgp, pumping digoxin back out before it is absorbed
Rifampin and St. John's Wort
________ works past beta-blockade but accumulates in renal impairment
Milrinone